IASO-782

N/A

Report date: 2026/04/30 20:00:20

Base Information

Drug NameIASO-782
Drug Alias NameIASO-782IASO782
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAnti-CD19
TargetsB-lymphocyte antigen CD19
Therapy Area/IndicationsLupus Erythematosus, SystemicPurpura, Thrombocytopenic, IdiopathicAnemia, Hemolytic, Autoimmune
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicPurpura, Thrombocytopenic, IdiopathicAnemia, Hemolytic, Autoimmune
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A